65
Current Status of Radiotherapy in Soft Tissue Sarcomas Martin Keisch, MD Cancer Healthcare Associates Miami Brachytherapy Center University of Miami Hospital

Current Status of Radiotherapy in Soft Tissue · PDF fileCurrent Status of Radiotherapy in Soft Tissue Sarcomas ... • Technique –Discuss various ... Wound healing after preoperative

Embed Size (px)

Citation preview

Current Status of Radiotherapy in Soft Tissue Sarcomas

Martin Keisch, MD

Cancer Healthcare Associates

Miami Brachytherapy Center

University of Miami Hospital

Outline

• Review Sarcoma Treatment Data – Retrospective Data – Randomized Data

• Technique – Discuss various techniques – External Beam

• Preoperative • Postoperative

– Brachytherapy alone – Brachytherapy boost + external beam – Treatment volume

• Toxicity and Function:

– Acute Wound Issues – Fibrosis

Background • History and Natural History

– Amputation as the standard surgical technique until last 40 years

– Local Failure common after conservative surgery alone-Relative radioresistance necessitates pushing dose intensity

– Hematogenous metastasis common

– Systemic management still questionable benefit

– Pathologic Classifications Evolving continually

– Group of diseases with low incidence

Pre-operative Therapy

•Used at some institutions to improve resectability

•Probably increases surgical complications

•Radiobiology is unclear due to potential for long break if post op boost needed

Post-Operative External Beam

•Bread and Butter of STS radiation

•“Easy”, Noninvasive, Least Targeted

•Probably increases late complication

Post-Operative Radiation

Brachytherapy

Major advantages are probably targeting accuracy and dose intensity/timing

Operator dependent

Probably increases acute wound complications

Post-operative XRT

after IORT

14-20 Gy

•Complex, Highly targeted

•Mobile Linear accelerator, or patient transport

•Few centers with capability

Basic Tenets of Radiotherapy

• More dose is better, Less volume is better

• No radiation is best

• The last 2 weeks of XRT are the hardest and most important

• Patient selection is key

• Techniques are local technology driven and sometimes user dependent

The Role of Radiation in Conservative Surgery

• 2 Randomized trials 1980’s-90’s

• NCI High Grade extremities

– 43 patients

– 4/27 LF CS vs. 0 in amputated group

– No diferrence in DFS or OS at five years

– + margins bad

• MSKCC mixed Grade

– 126 patients Brachytherapy vs. Conservative surgery only

– Decreased LF in BRT group for High Grade lesions

– No difference in DFS or Overall survival

From

Pisters et al

JCO Review 2007

Randomized trials for Modern Chemotherapy

• Adria/Ifos based- mid 1990’s

• 4 studies, small numbers (59-134 pts) -Frutasci et al, Petrioli et al, Brodawicz et al, Gortzak et al

• 2 positive, 2 negative

• Modest benefits at best

• Confounded by heterogeneous pathologic subtypes

Conservation Surgery and Radiation Grade 2/3

Study site Pt. # FUP yrs. LF % LF/DM % DM % RT Type

NCI 271 1-8 6 3 28 Post-op

MDA 190 5-16 21 7 25 Post-op

MGH 180 2-16 4 7 25 Pre-op

UCLA 255 2-15 5 2 24 Pre-op +Doxo

MSK 557 2-10 15 14 Pre/post/BRT+/-CT

Volumes - EBRT

Kim et al IJROBP

2D Radiation

Volumes - EBRT

• Reductions indicated? In the modern era of IMRT/IGRT

• Preoperatively on the the tumor NOT the operative bed (more like Brachytherapy)

• Postoperatively Much larger field sizes historically – need to target like Brachytherapy (need to go to the Operating Room)

Going to the OR

• But don’t want to do Brachytherapy?

• NOVAC 7: An IORT dedicated electron accelerator

• Conventional OR (no shielding needed)

• Mobile and easily docked

• Electron beams of 4 different energies: 3, 5, 7, 9 MeV

IORT MOBILE ACCELERATOR

Collimator

Skin separator

Foley catheter

Target

High Grade Retroperitoneal Liposarcoma

Resect ………..with IORT

Not going to the OR

• Didn’t think so…….

Wound healing after preoperative radiation for sarcoma of soft tissues.

Bujko K, Suit HD, Springfield DS, Convery K. Department of Radiation Oncology, Massachusetts General Hospital

– Morbidity from wound healing retrospectively analyzed – 202 consecutive patients with tumors of the soft tissue treated with

preoperative irradiation and conservative operation – boost dose was given to 143 patients (71 percent) postoperatively.

– The overall wound complication rate was 37 percent.

– One patient died because of necrotizing fasciitis.

– In 33 instances (16.5 percent), secondary operation was necessary,

including six patients (3 percent) who required amputation.

– The wounds in the remaining 40 patients (20 percent) were treated without operation.

IMRT Case

• 42 y male with enlarging left thigh mass x 4 mo

• Pain with sitting/pressure; sometimes difficulty in extending the legs

T1

Fat sat T1

Fat sat T1 Contrast

T2 Contrast

IMRT

IMRT Example #2

Volumes - Brachytherapy

• Volume collapses

• Margin is on the tumor not the operative bed

• 2 cm distal/proximal, less radially

• Discordant to both pre and post op EBRT volumes

Technique- Low vs. High Dose Rate

• LDR vs. HDR – LDR has more data

– More staff exposure

– Less flexibility

– HDR more image guided

– No staff exposure

• Best if brachytherapist present for entire resection

Geometry is everything

• Volume collapses after resection

Wound complications of adjuvant radiation therapy in patients with soft-tissue

sarcomas Ormsby MV, Hilaris BS, Nori D, Brennan MF

• loading of the catheters with radioactive sources on the first through the fifth postoperative days results in a 48% significant wound-complication rate

• catheters loaded five or more days after operation changed wound complications to 14% significant wound complications

• 10% of the 29 patients who did not receive radiation had wound complications of similar severity

• animal experiments would suggest that delay of application of radiation to one week after wounding is accompanied by significant improvement in wound-breaking strength, new H3 hydroxyproline accumulation, and improved force-tension curves

Ann Surg. 1989 Jul;210(1):93-9

MSKCC Low Dose Rate Implants

Mostly HDR Now

STIR T1

STIR

STIR

Posterior

calf

T1 (4.7 x 3.0 cm)

T2

Excision of tumor bed-

unplanned excision

T2

Re-Irradiation

• Highly conformal irradiation can limit

Toxicity from re-irradiation

• Data for benefit is limited Most series show high DM rate, significant complication

– MDAH series

• Tolerance generally good in my experience

Retreatment Case

• 80 yo female

• Presented with a new onset painless mass in her left thigh

• Past Hx of pleomorphic liposarcoma and post op Ext beam RTX (6300 cGY) in same location in 05-06

PE

• Diffuse swelling in LLE

• Well healed 20 cm scar on the medial aspect of thigh

• Radiation changes evident

• 2.0 x 2.0 cm firm mass palpable in the lower half of surgical incision.

• Bx done in office

FS T1 C+

1.4x1.3x1.3cm

STIR

2005

2005

Boost Case

• 77 yo female with left thigh mass

• Notes increasing mass over 6 months

• Melanoma in situ removed from left thigh 12 yrs ago – No further treatment, follow up

PE

• LLE:

– Mass anterior thigh (25 x 13 cm)

– Mild TTP; negative percussion; nonpulsatile

– Longitudinal incision ant-med mid thigh; well healed (prior melanoma)

GE T2

T1 T2

26 x 10 03/06

T1

T2

STIR

05/06

Boost to close or positive margins

Non-coplanar catheters useful

University of Miami Experience

• Brachy centric

• Analysis presented in abstract CORR

• Higher wound complication rate with Brachy especially in medial thigh

• Better Late tolerance even in patients with wound complications

Conclusions

• Very poorly studied due to low incidence and broad spectrum of pathologies and anatomic locations

• Volume and dose are critical to control and complications

• No single technique is clearly superior for all settings

• It is always worth observing the surgical resection

Issues not Covered

• Effect of close vs positive surgical margin

• Impact of unplanned excision on LC and OS

• Importance of percent necrosis after neoadjuvant chemotherapy